Lexicon Pharmaceuticals LXRX Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's other non-current liabilities?
- Lexicon Pharmaceuticals (LXRX) reported other non-current liabilities of $6.38M in Q1 2026.
- How has Lexicon Pharmaceuticals's other non-current liabilities changed year-over-year?
- Lexicon Pharmaceuticals's other non-current liabilities increased by 20.3% year-over-year, from $5.3M to $6.38M.
- What is the long-term trend for Lexicon Pharmaceuticals's other non-current liabilities?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's other non-current liabilities has grown at a 63.7% compound annual growth rate (CAGR), from $611K to $7.17M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.